Florence Van Obbergh

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations

Carla Al Assaf, Florence Van Obbergh, Johan Billiet et al. · Haematologica · 2015 · 63 citations · Full text

Essential Thrombocythemia, Genetics, Genetic Epidemiology +18

Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2

Nicolas Boissel, Françoise Huguet, Carlos Graux et al. · Blood · 2021 · 23 citations

Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study

Nicolas Boissel, Françoise Huguet, Thibaut Leguay et al. · Blood · 2022 · 23 citations

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

Jeroen J. W. M. Janssen, Bob Löwenberg, Markus G. Manz et al. · Leukemia · 2022 · 20 citations · Full text

Hematological Malignancy, Oncology, Elderly Patients +9

The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study

Florence Van Obbergh, Laurent Knoops, Timothy Devos et al. · Clinical Biochemistry · 2016 · 17 citations · Full text

Hematological Malignancy, Chronic Myeloid Leukemia, Imatinib Plasma +10